The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Tuberculosis Diagnostic-Global Market Insights and Sales Trends 2024
Synopsis
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
The global Tuberculosis Diagnostic market size is expected to reach US$ 3373.5 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Tuberculosis Diagnostic in various end use industries. The expanding demands from the Infants and Adults, are propelling Tuberculosis Diagnostic market. Radiographic Method, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diagnostic Laboratory Methods segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tuberculosis Diagnostic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tuberculosis Diagnostic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tuberculosis Diagnostic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tuberculosis Diagnostic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tuberculosis Diagnostic covered in this report include Thermo Fisher Scientific, Hologic Corporation, Abbott, Becton Dickinson, Roche, bioMerieux, Sanofi, Cepheid and Hain Lifescience, etc.
The global Tuberculosis Diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Hologic Corporation
Abbott
Becton Dickinson
Roche
bioMerieux
Sanofi
Cepheid
Hain Lifescience
QIAGEN
Global Tuberculosis Diagnostic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tuberculosis Diagnostic market, Segment by Type:
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Global Tuberculosis Diagnostic market, by Application
Infants
Adults
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Tuberculosis Diagnostic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
The global Tuberculosis Diagnostic market size is expected to reach US$ 3373.5 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Tuberculosis Diagnostic in various end use industries. The expanding demands from the Infants and Adults, are propelling Tuberculosis Diagnostic market. Radiographic Method, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diagnostic Laboratory Methods segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tuberculosis Diagnostic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tuberculosis Diagnostic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tuberculosis Diagnostic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tuberculosis Diagnostic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tuberculosis Diagnostic covered in this report include Thermo Fisher Scientific, Hologic Corporation, Abbott, Becton Dickinson, Roche, bioMerieux, Sanofi, Cepheid and Hain Lifescience, etc.
The global Tuberculosis Diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Hologic Corporation
Abbott
Becton Dickinson
Roche
bioMerieux
Sanofi
Cepheid
Hain Lifescience
QIAGEN
Global Tuberculosis Diagnostic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tuberculosis Diagnostic market, Segment by Type:
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Global Tuberculosis Diagnostic market, by Application
Infants
Adults
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Tuberculosis Diagnostic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Tuberculosis Diagnostic
1.1 Tuberculosis Diagnostic Market Overview
1.1.1 Tuberculosis Diagnostic Product Scope
1.1.2 Tuberculosis Diagnostic Market Status and Outlook
1.2 Global Tuberculosis Diagnostic Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Tuberculosis Diagnostic Market Size by Region (2018-2029)
1.4 Global Tuberculosis Diagnostic Historic Market Size by Region (2018-2023)
1.5 Global Tuberculosis Diagnostic Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Tuberculosis Diagnostic Market Size (2018-2029)
1.6.1 North America Tuberculosis Diagnostic Market Size (2018-2029)
1.6.2 Europe Tuberculosis Diagnostic Market Size (2018-2029)
1.6.3 Asia-Pacific Tuberculosis Diagnostic Market Size (2018-2029)
1.6.4 Latin America Tuberculosis Diagnostic Market Size (2018-2029)
1.6.5 Middle East & Africa Tuberculosis Diagnostic Market Size (2018-2029)
2 Tuberculosis Diagnostic Market by Type
2.1 Introduction
2.1.1 Radiographic Method
2.1.2 Diagnostic Laboratory Methods
2.1.3 Nucleic Acid Testing
2.1.4 Phage Assay
2.1.5 Detection of Latent Infection
2.1.6 Cytokine Detection Assay
2.1.7 Detection of Drug Resistance
2.2 Global Tuberculosis Diagnostic Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Tuberculosis Diagnostic Historic Market Size by Type (2018-2023)
2.2.2 Global Tuberculosis Diagnostic Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Tuberculosis Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Tuberculosis Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Tuberculosis Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Tuberculosis Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Tuberculosis Diagnostic Revenue Breakdown by Type (2018-2029)
3 Tuberculosis Diagnostic Market Overview by Application
3.1 Introduction
3.1.1 Infants
3.1.2 Adults
3.2 Global Tuberculosis Diagnostic Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Tuberculosis Diagnostic Historic Market Size by Application (2018-2023)
3.2.2 Global Tuberculosis Diagnostic Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Tuberculosis Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Tuberculosis Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Tuberculosis Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Tuberculosis Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Tuberculosis Diagnostic Revenue Breakdown by Application (2018-2029)
4 Tuberculosis Diagnostic Competition Analysis by Players
4.1 Global Tuberculosis Diagnostic Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2022)
4.3 Date of Key Players Enter into Tuberculosis Diagnostic Market
4.4 Global Top Players Tuberculosis Diagnostic Headquarters and Area Served
4.5 Key Players Tuberculosis Diagnostic Product Solution and Service
4.6 Competitive Status
4.6.1 Tuberculosis Diagnostic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Profile
5.1.2 Thermo Fisher Scientific Main Business
5.1.3 Thermo Fisher Scientific Tuberculosis Diagnostic Products, Services and Solutions
5.1.4 Thermo Fisher Scientific Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Recent Developments
5.2 Hologic Corporation
5.2.1 Hologic Corporation Profile
5.2.2 Hologic Corporation Main Business
5.2.3 Hologic Corporation Tuberculosis Diagnostic Products, Services and Solutions
5.2.4 Hologic Corporation Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)
5.2.5 Hologic Corporation Recent Developments
5.3 Abbott
5.3.1 Abbott Profile
5.3.2 Abbott Main Business
5.3.3 Abbott Tuberculosis Diagnostic Products, Services and Solutions
5.3.4 Abbott Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)
5.3.5 Becton Dickinson Recent Developments
5.4 Becton Dickinson
5.4.1 Becton Dickinson Profile
5.4.2 Becton Dickinson Main Business
5.4.3 Becton Dickinson Tuberculosis Diagnostic Products, Services and Solutions
5.4.4 Becton Dickinson Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)
5.4.5 Becton Dickinson Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche Tuberculosis Diagnostic Products, Services and Solutions
5.5.4 Roche Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Recent Developments
5.6 bioMerieux
5.6.1 bioMerieux Profile
5.6.2 bioMerieux Main Business
5.6.3 bioMerieux Tuberculosis Diagnostic Products, Services and Solutions
5.6.4 bioMerieux Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)
5.6.5 bioMerieux Recent Developments
5.7 Sanofi
5.7.1 Sanofi Profile
5.7.2 Sanofi Main Business
5.7.3 Sanofi Tuberculosis Diagnostic Products, Services and Solutions
5.7.4 Sanofi Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)
5.7.5 Sanofi Recent Developments
5.8 Cepheid
5.8.1 Cepheid Profile
5.8.2 Cepheid Main Business
5.8.3 Cepheid Tuberculosis Diagnostic Products, Services and Solutions
5.8.4 Cepheid Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)
5.8.5 Cepheid Recent Developments
5.9 Hain Lifescience
5.9.1 Hain Lifescience Profile
5.9.2 Hain Lifescience Main Business
5.9.3 Hain Lifescience Tuberculosis Diagnostic Products, Services and Solutions
5.9.4 Hain Lifescience Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)
5.9.5 Hain Lifescience Recent Developments
5.10 QIAGEN
5.10.1 QIAGEN Profile
5.10.2 QIAGEN Main Business
5.10.3 QIAGEN Tuberculosis Diagnostic Products, Services and Solutions
5.10.4 QIAGEN Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)
5.10.5 QIAGEN Recent Developments
6 North America
6.1 North America Tuberculosis Diagnostic Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Tuberculosis Diagnostic Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Tuberculosis Diagnostic Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Tuberculosis Diagnostic Market Dynamics
11.1 Tuberculosis Diagnostic Industry Trends
11.2 Tuberculosis Diagnostic Market Drivers
11.3 Tuberculosis Diagnostic Market Challenges
11.4 Tuberculosis Diagnostic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
